Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment
of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 1, 2021, Kimberly Alexy and John Bellizzi, each a Class II director
of the Board of Directors (the "Board") of Alteryx, Inc. (the "Company"), each
resigned as a member of the Board and all committees thereof, effective
November 10, 2021. Ms. Alexy's and Mr. Bellizzi's decisions to resign were each
based on personal reasons and were not due to a disagreement with the Company on
any matter relating to its operations, policies, or practices. In connection
with their respective resignations, the Board accelerated 2,397 outstanding
restricted stock units held by each of Mr. Bellizzi and Ms. Alexy.
Also on November 1, 2021, following recommendation from the Nominating and
Corporate Governance Committee of the Board, the Board appointed each of Daniel
J. Warmenhoven and CeCe Morken to serve as a director of the Company, effective
November 10, 2021. Each of Mr. Warmenhoven and Ms. Morken will serve as a
Class II director whose term will expire at the Company's 2022 annual meeting of
stockholders. Following recommendation from the Nominating and Corporate
Governance Committee of the Board, Mr. Warmenhoven was also appointed as a
member of the Compensation Committee and the Nominating and Corporate Governance
Committee, effective November 10, 2021. Following recommendation from the
Nominating and Corporate Governance Committee of the Board, Ms. Morken was
appointed as a member of the Audit Committee, effective November 10, 2021.
There is no arrangement or understanding between either of Mr. Warmenhoven or
Ms. Morken and any other persons pursuant to which he or she was selected as a
director. Neither Mr. Warmenhoven nor Ms. Morken has any direct or indirect
material interest in any transaction required to be disclosed pursuant to Item
404(a) of Regulation S-K. Each of Mr. Warmenhoven's and Ms. Morken's
compensation will be as provided under the Company's amended
non-employee director compensation policy as described in the Company's Proxy
Statement for the 2021 Annual Meeting of Stockholders as filed with the
Securities and Exchange Commission on March 31, 2021.
Each of Mr. Warmenhoven and Ms. Morken will enter into the Company's standard
form of indemnity agreement, which is attached as Exhibit 10.1 to the Company's
Registration Statement on Form S-1 filed with the SEC on February 24, 2017
(File No. 333-216237).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
ALTERYX, INC. 
